Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]        
Net revenue $ 5,051,000 $ 1,751,000 $ 10,585,000 $ 6,297,000
Cost of sales 4,402,000 1,690,000 9,461,000 5,968,000
Gross profit 649,000 61,000 1,124,000 329,000
Operating expenses:        
Selling and administrative expenses 2,584,000 2,421,000 7,108,000 5,518,000
Research and development 1,527,000 1,364,000 3,888,000 2,892,000
Total operating expenses 4,111,000 3,785,000 10,996,000 8,410,000
Operating loss (3,462,000) (3,724,000) (9,872,000) (8,081,000)
Interest expense (503,000) (90,000) (1,214,000) (1,058,000)
Net loss $ (3,965,000) $ (3,814,000) $ (11,086,000) $ (9,139,000)
Net loss per share - basic and diluted $ (0.78) $ (0.75) $ (2.17) $ (2.23)
Weighted average number of common shares outstanding - basic and diluted 5,107,845 5,076,967 5,105,982 4,105,433